Scimago Institutions Rankings
menu
| Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2019) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Drug Resistance Updates | journal | 3.920 Q1 | 105 | 17 | 67 | 3750 | 916 | 66 | 10.51 | 220.59 |  |
| 2 | Advances in Cancer Research | journal | 0.893 Q2 | 89 | 30 | 104 | 5564 | 564 | 13 | 29.38 | 185.47 | |
| 3 | Biochimica et Biophysica Acta - Reviews on Cancer | journal | 2.824 Q1 | 132 | 65 | 185 | 9717 | 1337 | 181 | 7.32 | 149.49 |  |
| 4 | Blood Reviews | journal | 2.049 Q1 | 90 | 64 | 144 | 7452 | 825 | 144 | 5.68 | 116.44 | |
| 5 | Cancer and Metastasis Reviews | journal | 2.810 Q1 | 142 | 63 | 164 | 7101 | 1139 | 154 | 6.22 | 112.71 | |
| 6 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.603 Q3 | 40 | 29 | 95 | 2940 | 241 | 94 | 2.63 | 101.38 |  |
| 7 | Cancer Treatment and Research | journal | 0.191 Q4 | 52 | 58 | 117 | 5358 | 181 | 20 | 0.00 | 92.38 | |
| 8 | Cancer Microenvironment | journal | 0.877 Q2 | 40 | 16 | 41 | 1472 | 113 | 39 | 2.50 | 92.00 |  |
| 9 | Expert Review of Anticancer Therapy | journal | 0.959 Q2 | 65 | 101 | 394 | 8621 | 1064 | 341 | 3.55 | 85.36 |  |
| 10 | Critical Reviews in Oncology/Hematology | journal | 2.213 Q1 | 119 | 196 | 608 | 16257 | 3442 | 602 | 6.06 | 82.94 | |
| 11 | Cancer Treatment Reviews | journal | 3.619 Q1 | 124 | 73 | 385 | 6027 | 3421 | 379 | 8.97 | 82.56 | |
| 12 | CA - A Cancer Journal for Clinicians | journal | 88.192 Q1 | 156 | 36 | 129 | 2924 | 22644 | 89 | 255.73 | 81.22 | |
| 13 | Journal of Hematology and Oncology | journal | 3.231 Q1 | 71 | 145 | 461 | 11769 | 4137 | 429 | 10.74 | 81.17 | |
| 14 | Current Cancer Drug Targets | journal | 0.893 Q2 | 89 | 81 | 230 | 6341 | 623 | 219 | 2.75 | 78.28 | |
| 15 | Journal of the National Cancer Institute. Monographs | journal | 0.875 Q2 | 84 | 23 | 17 | 1798 | 65 | 17 | 3.82 | 78.17 | |
| 16 | Cancers | journal | 1.938 Q1 | 64 | 2040 | 808 | 159193 | 4751 | 782 | 5.97 | 78.04 |  |
| 17 | Journal of Mammary Gland Biology and Neoplasia | journal | 0.959 Q2 | 96 | 29 | 62 | 2244 | 170 | 57 | 3.30 | 77.38 | |
| 18 | Gastric and Breast Cancer | journal | 0.111 Q4 | 6 | 13 | 21 | 1005 | 1 | 21 | 0.05 | 77.31 |  |
| 19 | Cancer Nanotechnology | journal | 1.299 Q2 | 21 | 11 | 32 | 781 | 190 | 29 | 5.10 | 71.00 | |
| 20 | Molecular Cancer | journal | 4.581 Q1 | 113 | 188 | 440 | 13341 | 6204 | 391 | 16.96 | 70.96 | |
| 21 | Endocrine-Related Cancer | journal | 1.545 Q1 | 124 | 107 | 435 | 7421 | 1792 | 393 | 4.55 | 69.36 | |
| 22 | Current Oncology Reports | journal | 1.490 Q1 | 55 | 113 | 261 | 7805 | 1025 | 261 | 3.89 | 69.07 | |
| 23 | Biologics: Targets and Therapy | journal | 0.697 Q3 | 36 | 17 | 50 | 1157 | 139 | 50 | 2.72 | 68.06 |  |
| 24 | Cellular Oncology | journal | 1.271 Q2 | 35 | 62 | 156 | 4183 | 734 | 152 | 5.07 | 67.47 | |
| 25 | Trends in Cancer | journal | 3.961 Q1 | 35 | 91 | 279 | 6113 | 2000 | 265 | 7.29 | 67.18 | |
| 26 | Revisiones en Cancer | journal | 0.100 Q4 | 2 | 9 | 106 | 604 | 1 | 106 | 0.01 | 67.11 |  |
| 27 | Current Hematologic Malignancy Reports | journal | 0.980 Q2 | 32 | 64 | 195 | 4289 | 513 | 192 | 2.63 | 67.02 | |
| 28 | Oncology Reviews | journal | 1.703 Q1 | 17 | 19 | 35 | 1241 | 194 | 34 | 6.00 | 65.32 |  |
| 29 | Current Treatment Options in Oncology | journal | 1.310 Q2 | 50 | 87 | 223 | 5657 | 818 | 218 | 3.87 | 65.02 | |
| 30 | Seminars in Radiation Oncology | journal | 1.202 Q2 | 89 | 43 | 131 | 2713 | 398 | 119 | 4.22 | 63.09 | |
| 31 | Current Colorectal Cancer Reports | journal | 0.462 Q3 | 22 | 23 | 120 | 1407 | 137 | 120 | 1.30 | 61.17 | |
| 32 | Journal of Oncology | journal | 0.937 Q2 | 50 | 243 | 81 | 14759 | 196 | 81 | 2.16 | 60.74 | |
| 33 | Therapeutic Advances in Medical Oncology | journal | 2.304 Q1 | 39 | 117 | 179 | 7077 | 1085 | 158 | 6.95 | 60.49 | |
| 34 | Seminars in Oncology | journal | 1.773 Q1 | 130 | 56 | 192 | 3382 | 655 | 162 | 4.27 | 60.39 | |
| 35 | Frontiers in Oncology | journal | 1.654 Q1 | 71 | 1379 | 1212 | 82795 | 5458 | 1135 | 4.89 | 60.04 | |
| 36 | Current Cancer Therapy Reviews | journal | 0.128 Q4 | 13 | 25 | 45 | 1482 | 10 | 38 | 0.36 | 59.28 | |
| 37 | Cancer Letters | journal | 2.356 Q1 | 172 | 435 | 1535 | 25394 | 10878 | 1475 | 7.23 | 58.38 |  |
| 38 | Cancer Journal | journal | 1.491 Q1 | 86 | 69 | 184 | 4022 | 514 | 161 | 3.39 | 58.29 | |
| 39 | Cancer Biology and Medicine | journal | 1.927 Q1 | 35 | 72 | 133 | 4055 | 711 | 131 | 5.55 | 56.32 |  |
| 40 | Surgical Oncology Clinics of North America | journal | 0.828 Q2 | 55 | 63 | 188 | 3538 | 399 | 152 | 2.07 | 56.16 | |
| 41 | Hematology/Oncology Clinics of North America | journal | 1.232 Q2 | 78 | 87 | 267 | 4855 | 747 | 228 | 3.14 | 55.80 | |
| 42 | Cytotherapy | journal | 1.233 Q2 | 81 | 109 | 426 | 6045 | 1560 | 379 | 3.90 | 55.46 | |
| 43 | Nature Reviews Cancer | journal | 21.287 Q1 | 418 | 138 | 366 | 7641 | 8532 | 204 | 37.77 | 55.37 | |
| 44 | Best Practice and Research in Clinical Haematology | journal | 0.802 Q3 | 73 | 57 | 146 | 3140 | 351 | 137 | 2.89 | 55.09 | |
| 45 | Molecular Therapy - Oncolytics | journal | 1.982 Q1 | 16 | 88 | 101 | 4822 | 536 | 100 | 4.06 | 54.80 | |
| 46 | Breast Cancer: Targets and Therapy | journal | 1.410 Q1 | 21 | 31 | 114 | 1697 | 396 | 108 | 3.40 | 54.74 | |
| 47 | Lung Cancer: Targets and Therapy | journal | 1.323 Q2 | 11 | 16 | 56 | 860 | 229 | 56 | 4.18 | 53.75 | |
| 48 | International Journal of Oncology | journal | 1.159 Q2 | 117 | 305 | 1388 | 16332 | 5364 | 1354 | 3.84 | 53.55 | |
| 49 | Current Breast Cancer Reports | journal | 0.520 Q3 | 16 | 48 | 100 | 2552 | 136 | 100 | 1.45 | 53.17 | |
| 50 | Journal of Carcinogenesis | journal | 2.689 Q1 | 37 | 6 | 11 | 319 | 126 | 11 | 13.33 | 53.17 |  |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2020. Data Source: Scopus®
Download data